Welcome to LookChem.com Sign In|Join Free
  • or
2-(benzoyloxy)-2-(diethoxyphosphoryl)acetic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

205264-82-0

Post Buying Request

205264-82-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

205264-82-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 205264-82-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,5,2,6 and 4 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 205264-82:
(8*2)+(7*0)+(6*5)+(5*2)+(4*6)+(3*4)+(2*8)+(1*2)=110
110 % 10 = 0
So 205264-82-0 is a valid CAS Registry Number.

205264-82-0Relevant academic research and scientific papers

Rh-DuPHOS-catalyzed enantioselective hydrogenation of enol esters. Application to the synthesis of highly enantioenriched α-hydroxy esters and 1,2-diols

Burk, Mark J.,Kalberg, Christopher S.,Pizzano, Antonio

, p. 4345 - 4353 (1998)

The asymmetric hydrogenation of α-(acetyloxy)- and α- (benzoyloxy)acrylates 4 catalyzed by cationic rhodium-DuPHOS complexes has been examined. A wide range of substrates (4) were prepared via a convenient Horner-Emmons condensation protocol, and subsequently hydrogenated under mild conditions (60 psi of H2) at substrate-to-catalyst ratios (S/C) of 500. Overall, enol ester substrates 4 were reduced by the cationic Et-DuPHOS-Rh catalysts with very high levels of enantioselectivity (93-99% ee). Importantly, substrates 4 bearing β-substituents could be employed as E/Z isomeric mixtures with no detrimental effect on the selectivity. Labeling studies indicated that no significant E/Z isomerization of the substrates occurs during the course of these reactions. Details concerning optimization of the reaction, interesting solvent effects, and deprotection procedures for the synthesis of highly enantioenriched α-hydroxy esters and 1,2-diols also are provided.

Novel therapeutic agents for the treatment of migraine

-

Page/Page column 29-30, (2010/02/14)

The present invention relates to compounds of Formula (I) as antagonists of calcitonin gene-related peptide receptors (“CGRP-receptor”), pharmaceutical compositions comprising them, methods for identifying them, methods of treatment using them and their u

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 205264-82-0